PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 128 filers reported holding PROTAGONIST THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $682,228 | -90.7% | 40,901 | -84.5% | 0.00% | -100.0% |
Q2 2023 | $7,303,032 | +14.2% | 264,411 | -4.9% | 0.00% | 0.0% |
Q1 2023 | $6,392,528 | +1757.0% | 277,936 | +780.9% | 0.00% | – |
Q4 2022 | $344,232 | +42.2% | 31,552 | +9.8% | 0.00% | – |
Q3 2022 | $242,000 | +3.9% | 28,724 | -2.6% | 0.00% | – |
Q2 2022 | $233,000 | -67.2% | 29,503 | -1.7% | 0.00% | – |
Q1 2022 | $711,000 | +4.9% | 30,026 | +51.5% | 0.00% | – |
Q4 2021 | $678,000 | +70.4% | 19,825 | -11.7% | 0.00% | – |
Q3 2021 | $398,000 | -51.1% | 22,452 | +23.9% | 0.00% | – |
Q2 2021 | $814,000 | +210.7% | 18,122 | +79.4% | 0.00% | – |
Q1 2021 | $262,000 | -92.9% | 10,103 | -94.7% | 0.00% | -100.0% |
Q3 2020 | $3,699,000 | -10.6% | 189,232 | -19.2% | 0.00% | 0.0% |
Q2 2020 | $4,137,000 | +590.7% | 234,281 | +175.9% | 0.00% | – |
Q1 2020 | $599,000 | -21.6% | 84,930 | +33.4% | 0.00% | – |
Q3 2019 | $764,000 | -25.7% | 63,653 | -25.0% | 0.00% | – |
Q2 2019 | $1,028,000 | +14.7% | 84,849 | +19.0% | 0.00% | – |
Q1 2019 | $896,000 | +82.9% | 71,313 | -2.3% | 0.00% | – |
Q2 2018 | $490,000 | +1.2% | 72,964 | +29.6% | 0.00% | – |
Q1 2018 | $484,000 | – | 56,308 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 2,449,183 | $67,646,434 | 21.00% |
COWEN AND COMPANY, LLC | 1,657,551 | $45,781,558 | 3.80% |
Kynam Capital Management, LP | 975,298 | $26,937,731 | 3.70% |
BVF INC/IL | 3,775,900 | $104,290,358 | 2.91% |
RTW INVESTMENTS, LP | 5,415,514 | $149,576,497 | 2.85% |
Cormorant Asset Management, LP | 1,500,000 | $41,430,000 | 2.32% |
Ghost Tree Capital, LLC | 225,000 | $6,214,500 | 2.05% |
683 Capital Management, LLC | 814,000 | $22,482,680 | 1.62% |
Perceptive Advisors | 1,469,761 | $40,594,799 | 1.18% |
Artia Global Partners LP | 112,340 | $3,102,831 | 1.07% |